Health Condition 1: null- Morbidly obese patients(BMI more than 40Kg/m2 or BMI more than 35Kg/M2 with an obesity related co-morbidty), posted for laparoscopic bariatric surgery
Conditions
Interventions
None listed
Sponsors
Narani KK
Eligibility
Inclusion criteria
Inclusion criteria: Patients with morbid obesity (BMI more than 40 Kg/m2 or BMI more than 35 Kg/m2 with an obesity related co-morbidity), undergoing laparoscopic bariatric surgery
Exclusion criteria
Exclusion criteria: 1. Patients on anticoagulants or antiplatelet drugs 2. Patients with h/o DVT and PE 3. Chronic liver disease (serum bilirubin above 2mg/dl) 4. Chronic renal disease (Cr Cl less than 30ml/min)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-Xa levels - 2.7 ml of blood collected in Vacutainers (BD Franklin Lakes, NJ, USA), containing Buff. Na citrate, 0.109 M, 3.2%,to monitor anti-Xa levels Timepoint: Anti-Xa levels 1. On the day of surgery, before starting operation at 8 AM (12 hrs after 1st dose of enoxaparin) 2. 4 hrs after after the dose of enoxaparin, administered 8 hrs after surgery 3. 2nd postoperative day, 4 hrs after the dose of enoxaparin 4. 8th postoperative day, 4 hrs after the dose of enoxaparin 5.15th postoperative day, 4 hrs after the dose of enoxaparin 6. 30th postoperative day, 4 hrs after the dose of enoxaparin | — |
Secondary
| Measure | Time frame |
|---|---|
| Ultrasound clour Doppler mapping of leg veins to rule out presence of any asymptomatic DVTTimepoint: Preoperatve, on 8th and 30th postoperative days | — |
Countries
India
Contacts
Public ContactNarani KK
Sir Ganga Ram Hospital
Outcome results
None listed